Advanced Biomed is trading at $4.34, down 10.70%, with no specific catalyst established. - No fresh company-specific announcement was identified to explain the October 16 decline. - The latest company items were an October 13 earnings report and a September 28 late-filing notice. - The biotech sector is reported up 2.20%, so its trend does not explain the stock’s decline.